The Ugi reaction with formylphenylboronic acid derivatives as the carbonyl component proceeds to give the corresponding boroncontaining dipeptide derivatives (Ugi products) in good yields.
Introduction
Compounds containing boronic acids [RB(OH) 2 ] or boronate esters [RB(OR') 2 ] are remarkably useful precursors for the Suzuki-Miyaura cross coupling reactions [1] and as molecular recognition sensors [2] [3] [4] [5] . Interest in these compounds also arises from their potent biological activities [6] [7] [8] [9] [10] [11] [12] [13] . For instance, boron amino acid derivatives ( Figure 1a ) are strong inhibitors of human arginase II, whose primary function appears to be in L-arginase homeostasis. Related α-aminoboronic acid derivatives are also well known for their ability to act as serine protease inhibitors [7] . Bortezomib (PS-341, Velcade; Figure 1b ) is a novel boronic acid dipeptide that potently, selectively, and reversibly inhibits 26S proteasome and was developed specifically for the therapy of human tumours [14, 15] . Preclinical studies have shown that Bortezomib inhibited proliferation at a mean IC 50 of 7 nM in 60 cell lines included in the National Cancer Institute's panel. Amino acid derivatives containing boron have also been investigated for their use in boron neutron capture therapy (BNCT) for the treatment of cancer [16] [17] [18] [19] [20] [21] [22] . BNCT is a bimodal form of therapy that depends on selectively depositing boron-10 atoms into the cancerous tumour prior to irradiation by slow neutrons. 4-Dihydroxyborylphenylalanine ( Figure 1c ) has shown promise in the treatment of brain tumours [17] .
Boron compounds are also known to display powerful antimicrobial properties. For instance, it has been recently discovered that 5-fluoro-1,3-dihydro-1-hydroxy-2,1-benzoxarole is a powerful broad-spectrum antifungal agent (Figure 1d ) [23] . The molecule's potency stems from the boron atom's ability to form a stable adduct with the 2′-and 3′-oxygen atoms of the leucyl-tRNA synthetase, effectively inhibiting the enzyme. Due to the biological activities displayed by these and other boron-containing compounds, a considerable amount of research has focused on the synthesis of these potentially valuable compounds.
As part of our ongoing investigation into making novel boron compounds, [24] [25] [26] and considering the wealth of bioactivities found in aminoboronic acid derivatives, we decided to examine the synthesis of Ugi products derived from pinacol protected formylphenylboronic acids. The multicomponent Ugi reaction readily provides amino acid analogs [27] [28] [29] [30] [31] . Although new compounds will be structurally similar to Bortezomib, they will not be α-aminoboronic acid derivatives and are not expected to have similar bioactivities. However, we have reported that amine derivatives containing boronic acids and boronate esters display considerable antifungal activity [25] . As such, all new boron-containing Ugi products may display fungicidal activity.
Experimental Procedures

General
Reagents and solvents used were obtained from Aldrich Chemicals. 1 
Synthesis
A formylphenylboronate ester (4.00 mmol) was either (i) added to benzoic acid (4.00 mmol) and p-anisidine (4.00 mmol) in EtOH (15 mL) and stirred for 30 min or (ii) added to β-alanine (4.00 mmol) in MeOH (5 ml) and stirred for 30 min. A EtOH or MeOH (15 mL) solution of benzylisocyanide (4.00 mmol) was added dropwise to the solution and the mixture was stirred for 4-10 days. Following the removal of solvent under vacuum, the resulting mixture was dissolved in either (i) Et 2 O (25 mL) or (ii) THF/hexane(10%) and stored at 5 o C for 4 days. A precipitate was collected by suction filtration and washed with hexanes (3 x 5 mL) and cold Et 2 O (3 x 2 mL) to afford the desired product. (3-(4,4,5,5- 
N-((Benzylcarbamoyl)
tetramethyl-1,3,2- dioxaborolan-2-yl)phenyl)methyl)-N-(4-methoxyphenyl
N-((Benzylcarbamoyl)(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methyl)-N-(4-methoxyphenyl
N -( ( B e n z y l c a r b a m o y l ) ( 2 -m e t h o x y -5 -( 4 , 4 , 5 , 5 -tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methyl)-N-(4-methoxyphenyl)benzamide
N-Benzyl-2-(4-(4,4,5,5-tetramethyl-1,3,2,-dioxaborolan-2-yl)phenyl)-2-(2-oxoazetidin-1yl)acetamide
N-Benzyl-2-(2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2,-dioxaborolan-2-yl)phenyl)-2-(2-oxoazetidin-1yl) acetamide
X-ray diffraction studies
Crystals of 3' were grown from a saturated MeOH solution at 20 o C. Single crystals were coated with Paratone-N oil, mounted using a glass fibre and frozen in the cold stream of the goniometer. A hemisphere of data were collected on a Bruker AXS P4/SMART 1000 diffractometer using ω and θ scans with a scan width of 0.3 o and exposure time of 30 s. The detector distance was 5 cm. The data were reduced [32] and corrected for absorption [33] . The structures were solved by direct methods and refined by full-matrix least squares on F 2 [34] . All non-hydrogen atoms were refined anisotropically. Hydrogen atoms were located in Fourier difference maps and refined isotropically. Crystallographic information has also been deposited with the Cambridge Crystallographic Data Centre (CCDC 681430).
Results and Discussion
A multicomponent reaction (MCR) involves a series of bimolecular events that eventually leads to products containing almost all the atoms of three or more starting materials. One of the most widely used MCR is the Ugi reaction (U-4CR), whereupon condensation of readily available aldehydes, carboxylic acids, amines and isocyanides provides a straightforward route to amino acid analogues. The reaction is believed to proceed by initial condensation of the amine with the aldehyde to form a transient imine via a hydroxy aminal. The acid component is then believed to protonate the nitrogen atom of the imine, thus increasing the electrophilicity of the C=N bond. Addition of the electrophilic iminium ion and nucleophilic carboxylate anion to the carbenoid carbon of the isocyanide would generate the corresponding α-adduct, an iminoanhydride. Finally, an intramolecular acylation, known as the Mumm rearrangement, would afford a stable Ugi product. In this study, we examined the preparation of Ugi products derived from pinacol protected, commercially available aldehydes containing boronic acids, benzylisocyanide, and either benzoic acid and 4-anisidine, or β-alanine (Scheme 1).
All new compounds have been prepared in good yields and characterized by a number of physical methods including multinuclear NMR spectroscopy. A broad peak at around 30 ppm in the 11 B NMR spectra suggests that the boron atom lies in a three coordinate environment in solution [35] . This result is somewhat surprising in light of boron's propensity to form coordinate bonds with Lewis basic atoms [36] [37] [38] . Previous studies have shown that compounds containing boronic acids can be extremely difficult to characterize in terms of elemental composition, owing to the ease with which they partially dehydrate to the corresponding trimeric and oligomeric anhydrides [39, 40] . Attempts to crystallize compound 3 in MeOH resulted in a single crystal X-ray diffraction study on 3', ( Figure 2 , Table 1 ) where the pinacol group has been cleaved, and replaced with one hydroxyl group and one methoxy group on the boron atom. The B-O bond distances of 1.3532(19) and 1.363(2) Å are typical for those observed in other three coordinate boron compounds [41] [42] [43] [44] . No appreciable intermolecular interaction between the Lewis acidic boron atom and the amide groups is observed in the solid state.
By employing the β-aminoacid, β-alanine, as a single source for both the amine and the carboxylic acid, an Ugi four-center three component reaction (U-4C-3CR) was used to generate a series of β-lactam-containing compounds (4-6). Compounds containing a β-lactam moiety have been used extensively as antimicrobial agents [45, 46] . It is hoped that the presence of both a boron group and a β-lactam moiety will provide enhanced biological activities for these novel boroncontaining dipeptide derivatives. Initial attempts to use these Ugi products containing boronate esters as synthons for the Suzuki-Miyaura cross-coupling reaction have been successful and we will report our findings in due course.
Conclusions
In summary, we have prepared new Ugi compounds from the addition of pinacol protected, commercially available aldehydes containing boronic acids, benzylisocyanide, and benzoic acid and 4-anisidine in a 4-CR. A 3-CR produced the first β-lactam Ugi products containing boronate esters. Products have been characterized by a number of physical methods, including an X-ray diffraction study for 3'. These novel boron-containing Ugi products will be tested for their potential antimicrobial activities.
